Regulatory & Access Portal Assets

This Stream includes all of our Access Portal Assets Flipbooks

How to interact virtually with health authorities

View Now
Three ways to power up your real-world evidence portfolio with a registry

View Now
Using real-world evidence to help your product succeed

View Now
Plan & Engage Early To Manage the Risks of Risk Management

View Now
Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success

Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success

View Now
What to look for in a partner to support biosimilar initiatives

This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.

View Now
Market Access Consulting Brochure

View Now
Strengthen Your Product Value Story One Phase At A Time

Find out how to plan evidence generation for your value story!

View Now
How-multi-stakeholder-strategies-for-ECAs-can-overcome-approval-and-access-barriers.May.Endpts.News

View Now
Services factsheet: EU Clinical Trial Regulation (CTR) 536/2014

View Now
Impending avalanche of regulatory compliance activity: Are you prepared?

View Now
Early Genomics Strategy_Article

View Now
Top ten rules for success in decentralized trials

View Now
Six top tips to prepare for the new EU Clinical Trial Regulation

View Now
3 ways to reap the benefits of adaptive-trials

View Now
Dosing strategies for gene therapies

In this article, our gene therapy experts at Health Advances, Parexel’s commercial strategy group, outline considerations for competitively positioning your gene therapy.

View Now
Parexel Sample_PowerPoint Illustration

View Now
Parexel Sample_Mobile Ready Infographic

View Now
Parexel Sample_Interactive Poster

View Now
COVID-19 HEALTH AUTHORITY UPDATES 18 DECEMBER 2020

View Now
Loading More...